Medline Inc. (MDLN)
NASDAQ • Healthcare
Last close at September 21, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Medline Inc. keeps $1 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 43 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Medline beat consensus on both the top and bottom line in the second fiscal quarter of 2026, reported Aug. 5, with adjusted EPS of $0.50 topping the $0.35 estimate, +42%, and revenue of $7.685 billion topping the $7.519 billion estimate, +2.2%. Revenue rose 11.6% from about $6.9 billion a year ago, with gross margin near 29% and operating margin around 5% as operating income came to about $395 million; net income fell 82.0% to about $60 million from about $333 million a year ago, and operating cash flow was about $715 million. Next-period consensus calls for EPS of $0.34 on revenue of $7.722 billion.
About Medline Inc.
Medline Inc. trades on the NASDAQ under MDLN and operates in healthcare as a maker and distributor of medical instruments and supplies. Its business spans wound care treatments, examination gloves, and a broader range of clinical and surgical products, and it generated $28.4 billion of revenue in FY2025.
Today's Snapshot
The day ended with MDLN 1% higher at 31.96, in line with a firmer sector. MDLN closed within 1.5% of its 52-week low of 31.49.
Trading Volume
Above 10d avg 8.7M
10.4M
vs S&P 500 Today
Underperforming Market
-0.60%
Updated: September 21, 2026 at 21:29 UTC
Peers & Related Assets
Get premium market insights delivered directly to your inbox.